Full-year results announcement for the year ended 30 September 2025

Double-digit operating profit growth with both regions performing strongly

Net new business growth in 4-5% target range for the fourth consecutive year

Group organic revenue growth of 8.7%:

• North America organic revenue up 9.1% and International up 7.7%
• Net new business growth of 4.5%, particularly strong in North America
• Group client retention rate continues to be strong at over 96%
• Secured new business of $3.8bn⁴, an 11%² increase year on year

Underlying operating profit increased by 11.7%² to over $3.3bn:

• Consistent underlying operating margin progress, increasing to 7.3% in H2 2025
• Strong cash generation with underlying free cash flow of $2.0bn; 88% conversion rate

Invested $1.5bn in capex (3.3% of revenue) and $1.3bn in M&A for future growth:

• Continuing to strengthen our business model as we leverage sectorisation with scale
• Expanding our total addressable market, now worth c.$360bn⁵, through additional capabilities
• Agreed to acquire Vermaat⁶, an exceptional premium food services business in Europe, for c.€1.5bn ($1.8bn)
• Integration of recent acquisitions ahead of schedule with M&A contributing to profit growth

Outlook:

• For 2026, we expect underlying operating profit growth² of around 10% driven by organic revenue growth around 7.0%, around 2% profit growth from M&A (including Vermaat) and ongoing margin progression
• Longer term, we remain confident in sustaining mid-to-high single-digit organic revenue growth, ongoing margin progression and profit growth ahead of revenue growth

Statutory results:

• Revenue increased by 9.7% reflecting the strong trading performance
• Operating profit, including non-underlying charges related to business acquisitions and reshaping our portfolio, increased by 14.7% to $2,964m

Dominic Blakemore, Group Chief Executive, said:

“2025 was another strong year for Compass, delivering underlying operating profit growth of nearly 12%¹ on a constant-currency basis, with both regions performing well. Net new business, the cornerstone of our growth, remained firmly within our 4-5% target range for the fourth consecutive year, underpinned by strong new business wins and client retention.

We are continuing to strengthen our business model, which leverages the flexibility of our bespoke sector portfolio with significant global scale, by investing in high-quality platform acquisitions in Europe. This provides us with further long-term value creation opportunities and follows our established and proven track record of successful M&A in North America, which has unlocked decades of high growth and strong returns.

Our latest agreement to acquire Vermaat² in the Netherlands, an exceptional premium food services business, will further improve our delivery of tailored on-site concepts and innovative retail solutions, as well as bringing exceptional talent. Furthermore, the integration of completed acquisitions is progressing well, and following the conclusion of our disposal programme, are now contributing to profit growth.

This year’s strong trading performance, combined with the significant market opportunity, which keeps expanding as we add new capabilities through M&A, reinforces our confidence in the sustainability of our long-term growth algorithm.

For 2026, we expect underlying operating profit growth³ of around 10%¹ driven by organic revenue growth around 7.0%¹, around 2% profit growth from M&A (including Vermaat) and ongoing margin progression. Longer term, we remain confident in sustaining mid-to-high single-digit organic revenue growth with ongoing margin progression, leading to profit growth ahead of revenue growth.”

^{1.    Reconciliation of statutory to underlying results can be found in notes 2 (segmental analysis) and 14 (non-GAAP measures) to the consolidated financial statements.}

^{2.    Measured on a constant-currency basis.}

^{3.    Organic revenue change.}

^{4.    Annual revenue of new business wins in the last 12 months.}

^{5.    Based on management estimates.}

^{6.    Subject to regulatory approval.}